GRIZEL BELLO BARJA: Open Payments
NPI 1730870817 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 15 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $165 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| ARGENX US, INC. | 11 | $316 |
| AstraZeneca Pharmaceuticals LP | 2 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $17 |
Products named: VYVGART, SAPHNELO, VYVGART HYTRULO, HYQVIA, KISUNLA.
Industry payments across NC — which companies pay providers there.
